[Retracted] Circular RNA circFAT1(e2) Facilitates Cell Progression through the miR-30e-5P/MYBL2 Pathway in Glioma

Figure 2

Prognostic analysis of MYBL2. (a) Survival analysis on MYBL2 expression in primary glioma. The survival rate of high MYBL2 expression was poor. (b) Survival analysis on MYBL2 expression in recurrent glioma. The survival rate of high MYBL2 expression was poor. (c, d) Cox regression study on MYBL2 and clinical variables (MYBL2, age, gender, race, and grade), both univariate and multivariate. (e) In glioma patients, the nomogram predicts 1-, 3-, and 5-year overall survival. (f) The ideal nomogram is represented by the diagonal dashed line on the calibration curve of the OS nomogram model.

(a)

(b)

(c)

(d)

(e)

(f)